stage iv non-small cell lung cancer Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Unknown (1)

Observational (1)

European Lung Cancer Working Party (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadlung cancer

I am/have/hadsmall cell lung cancer

I am/have/hadcancer

I am/have/hadstage iv non-small cell lung cancer

I am/have/hadchemoradiotherapy

I am/have/hadcarcinoma

I am/have/hadstage iii non-small cell lung cancer

I am/have/hadcarcinoma in situ

I am/have/hadsalvage therapy

I am/have/hadcarcinoma of the cervix

I am/have/hadnon-melanoma skin cancer

added new label for I am/have/had

more

I am looking for

I am looking foradjuvant

I am looking formelanoma

I am looking forimmunomodulators

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

For Seniors
For adults
Recruiting in 100s
Observational Study
all
Family Medicine
Recruiting

Immunotherapy in Lung Cancer: Treatment After IO Cessation.

Immunotherapy is now a standard of care for first-line and eventually salvage therapy in patients with stage IV NSCLC and as adjuvant after RT-CT for stage III NSCLC. The aim of the study is determining the therapeutic landscape and the reason for immunotherapy cessation.

carcinoma in situ

melanoma

carcinoma of the cervix

immunomodulators

non-melanoma skin cancer

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.